Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, 110 029, India.
Department of Gastrointestinal Surgery, All India Institute of Medical Sciences, New Delhi, 110 029, India.
Indian J Gastroenterol. 2022 Jun;41(3):273-283. doi: 10.1007/s12664-021-01217-0. Epub 2022 Apr 26.
Optimal outcomes in acute severe ulcerative colitis (ASUC) are related to time-bound management based upon early prediction of response to intravenous (IV) steroids. In an earlier study, we described the All India Institute of Medical Sciences (AIIMS) index (baseline Ulcerative Colitis Endoscopic Index of Severity [UCEIS] ≥ 7 and day 3 fecal calprotectin [FCP] > 1000 μg/g) for predicting failure of IV steroids. The current study is designed to validate this index in a prospective cohort.
IV steroid-naïve patients with ASUC, satisfying Truelove and Witts' criteria, hospitalized from August 2018 to July 2019 were included. Patients' assessment included baseline sigmoidoscopy, day 1 and 3 FCP, hemogram, biochemistry and day 3 C-reactive protein. All patients received IV steroids, and the primary outcome was steroid failure, defined as the need for colectomy or rescue therapy with cyclosporine (CYC)/infliximab (IFX) during admission.
Of the 47 patients, eight were excluded (four received steroids outside, two were directly taken for surgery/infliximab therapy, one had toxic megacolon, and one had infectious colitis), and 39 patients were included (mean age: 36.1 ± 12.6 years, male: 31%). Fifteen patients (38%) failed IV steroid and required rescue therapy (IFX: 9, CYC: 2, Colectomy: 3, IFX followed by colectomy: 1). On univariate analysis, UCEIS ≥ 7 at baseline (p = 0.006), day 1 FCP (p = 0.03), day 3 FCP > 1000 μg/g (p = 0.001), Oxford criteria (p = 0.04) and AIIMS index (p < 0.001) were significantly different between steroid responders and steroid failures. On multivariate analysis, day 3 FCP > 1000 μg/g (odds ratio (odds ratio (OR)= 6.4;(95% CI =2.2-196.1) and baseline UCEIS ≥ 7 (OR) = 10.1;(95% CI = 2.1-80.2) were independent predictors. The AIIMS index predicted steroid failure with a better specificity (100% vs. 83%, p = 0.04) and positive predictive value (100% vs. 64%, p = 0.03) than Oxford criteria.
AIIMS index has been validated in 39 prospective ASUC patients as an effective early predictor of steroid failure (sensitivity = 53%, specificity = 100%).
急性重度溃疡性结肠炎(ASUC)的最佳治疗效果与基于对静脉(IV)皮质类固醇反应的早期预测的限时管理有关。在早期的一项研究中,我们描述了全印度医学科学研究所(AIIMS)指数(基线溃疡性结肠炎内镜严重指数[UCEIS]≥7 且第 3 天粪便钙卫蛋白[FCP]>1000μg/g)用于预测 IV 皮质类固醇治疗失败。本研究旨在前瞻性队列中验证该指数。
纳入 2018 年 8 月至 2019 年 7 月因 ASUC 住院且初次接受 IV 皮质类固醇治疗的 Truelove 和 Witts 标准患者。患者评估包括基线乙状结肠镜检查、第 1 天和第 3 天 FCP、血常规、生化和第 3 天 C 反应蛋白。所有患者均接受 IV 皮质类固醇治疗,主要结局为皮质类固醇治疗失败,定义为在住院期间需要行结肠切除术或用环孢素(CYC)/英夫利昔单抗(IFX)进行挽救性治疗。
47 例患者中,8 例被排除(4 例在院外接受皮质类固醇治疗,2 例直接接受手术/英夫利昔单抗治疗,1 例患有中毒性巨结肠,1 例患有感染性结肠炎),39 例患者被纳入(平均年龄:36.1±12.6 岁,男性:31%)。15 例(38%)患者皮质类固醇治疗失败,需要挽救性治疗(IFX:9 例,CYC:2 例,结肠切除术:3 例,IFX 后结肠切除术:1 例)。单因素分析显示,基线 UCEIS≥7(p=0.006)、第 1 天 FCP(p=0.03)、第 3 天 FCP>1000μg/g(p=0.001)、牛津标准(p=0.04)和 AIIMS 指数(p<0.001)在皮质类固醇反应者和皮质类固醇失败者之间存在显著差异。多因素分析显示,第 3 天 FCP>1000μg/g(比值比(OR)=6.4;95%CI=2.2-196.1)和基线 UCEIS≥7(OR)=10.1;95%CI=2.1-80.2)是独立的预测因子。AIIMS 指数预测皮质类固醇治疗失败的特异性(100% vs. 83%,p=0.04)和阳性预测值(100% vs. 64%,p=0.03)均优于牛津标准。
在 39 例前瞻性 ASUC 患者中,AIIMS 指数被验证为皮质类固醇治疗失败的有效早期预测指标(敏感性=53%,特异性=100%)。